ELAVL1 and breast cancer: Previous studies have reported that METTL14 forms a negative feedback loop with ALKBH5/TFEB in cardiomyocytes treated with hypoxia/reoxygenation [41] and constitutes a positive one with ALKBH5/HuR in breast cancer [42].